Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements

Abstract Background Transcatheter aortic valve replacement (TAVR) has evolved into a routine procedure with good outcomes in high-risk patients. Objectives TAVR complication rates were evaluated based on prospective data from the German Aortic Valve Registry (GARY). Methods From 2011 to 2013, a tota...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-05, Vol.65 (20), p.2173-2180
Hauptverfasser: Walther, Thomas, MD, Hamm, Christian W., MD, Schuler, Gerhard, MD, Berkowitsch, Alexander, MD, Kötting, Joachim, Dipl Stat, Mangner, Norman, MD, Mudra, Harald, MD, Beckmann, Andreas, MD, Cremer, Jochen, MD, Welz, Armin, MD, Lange, Rüdiger, MD, Kuck, Karl-Heinz, MD, Mohr, Friedrich W., MD, Möllmann, Helge, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background Transcatheter aortic valve replacement (TAVR) has evolved into a routine procedure with good outcomes in high-risk patients. Objectives TAVR complication rates were evaluated based on prospective data from the German Aortic Valve Registry (GARY). Methods From 2011 to 2013, a total of 15,964 TAVR procedures were registered. We evaluated the total cohort for severe vital complications (SVCs), including the following: death on the day of intervention, conversion to sternotomy, low cardiac output that required mechanical support, aortic dissection, and annular rupture; technical complications of the procedures (TCOs), such as repositioning or retrieval of the valve prosthesis and embolization of the prosthesis; and other complications. Results Mean patient age was 81 ± 6 years, 54% of the patients were women, the median logistic Euroscore I was 18.3, the German aortic valve score was 5.6, and the Society of Thoracic Surgeons score was 5.0. Overall in-hospital mortality was 5.2%, whereas SVCs occurred in 5.0% of the population. Independent predictors for SVCs were female sex, pre-operative New York Heart Association functional class IV, ejection fraction 
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.03.034